In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Magnesium hydroxide suspension Drug Master File in Korea (Magnesium hydroxide suspension KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Magnesium hydroxide suspension. The MFDS reviews the Magnesium hydroxide suspension KDMF as part of the drug registration process and uses the information provided in the Magnesium hydroxide suspension KDMF to evaluate the safety and efficacy of the drug.
After submitting a Magnesium hydroxide suspension KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Magnesium hydroxide suspension API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Magnesium hydroxide suspension suppliers with KDMF on PharmaCompass.